Glucagon-Like Peptide-1 Receptor Agonists in Hidradenitis Suppurativa
Louise Gouvrion, M. Delage, A. Villani, S. Le Naour, C. Fite, C. Cassius, L. Misery, Bénédicte Oulès, Alice Mouna Fayad, A. Brun, C. Pruvost‐Balland, Gilles Safa, M. Tardieu, S. Buche, A. Maruani, G. Quéreux, Aude Nassif, Agathe Guénégo, Ronan Thibault, A. Dupuy, F. Poizeau, IGDO (Institut de Dermatologie du Grand-Ouest), HS-France group of the French Society of Dermatology
Abstract
This cohort study investigates the potential therapeutic benefits of glucagon-like peptide-1 receptor agonists in patients with hidradenitis suppurativa.
Topics & Concepts
Hidradenitis suppurativaMedicineGlucagon-like peptide-1DermatologyReceptorDiabetes mellitusInternal medicineEndocrinologyDiseaseType 2 diabetesHidradenitis Suppurativa and Treatments